APA

Brenner M. K., Heslop H., Krance R., Horowitz M., Strother D., Nuchtern J., Grilley B., Martingano E. & Cooper K. (20001102). Phase I study of chemokine and cytokine gene-modified autologous neuroblastoma cells for treatment of relapsed/refractory neuroblastoma using an adenoviral vector. : Human gene therapy.

Chicago

Brenner M K, Heslop H, Krance R, Horowitz M, Strother D, Nuchtern J, Grilley B, Martingano E and Cooper K. 20001102. Phase I study of chemokine and cytokine gene-modified autologous neuroblastoma cells for treatment of relapsed/refractory neuroblastoma using an adenoviral vector. : Human gene therapy.

Harvard

Brenner M. K., Heslop H., Krance R., Horowitz M., Strother D., Nuchtern J., Grilley B., Martingano E. and Cooper K. (20001102). Phase I study of chemokine and cytokine gene-modified autologous neuroblastoma cells for treatment of relapsed/refractory neuroblastoma using an adenoviral vector. : Human gene therapy.

MLA

Brenner M K, Heslop H, Krance R, Horowitz M, Strother D, Nuchtern J, Grilley B, Martingano E and Cooper K. Phase I study of chemokine and cytokine gene-modified autologous neuroblastoma cells for treatment of relapsed/refractory neuroblastoma using an adenoviral vector. : Human gene therapy. 20001102.